Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study.

Pietzner, Klaus

Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study. [electronic resource] - Medical oncology (Northwood, London, England) Dec 2014 - 308 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

1559-131X

10.1007/s12032-014-0308-x doi


Aged
Aged, 80 and over
Antibodies, Bispecific--administration & dosage
Ascites--drug therapy
Female
Humans
Infusions, Parenteral
Male
Middle Aged
Peritoneal Neoplasms--drug therapy
Quality of Life
Survival Analysis
Treatment Outcome